Abstract
A series of erythrose, ribose, and substituted pyrrolidine containing 2,4-thiazolidinediones were synthesized. Among them, thirteen unsaturated thiazolidinediones, six saturated thiazolidinediones and two unsaturated malonates were evaluated for their ability to enhance glucose utilization in cultured L6 myocytes. On the basis of the in vitro activity, 5-{4-[2-(1-benzyl-3,4-bis-benzyloxypyrrolidin-2-yl)ethoxy]benzylidene} thiazolidine-2,4-dione 24b was selected as the candidate for further pharmacological studies.
Original language | English |
---|---|
Pages (from-to) | 276-285 |
Number of pages | 10 |
Journal | Chemical and Pharmaceutical Bulletin |
Volume | 51 |
Issue number | 3 |
DOIs | |
Publication status | Published - 2003 Mar |
Keywords
- Erythrose
- Glucose utilization
- Insulin sensitizing agent
- Ribose
- Substituted pyrrolidine
- Thiazolidinedione
ASJC Scopus subject areas
- Chemistry(all)
- Drug Discovery